Related Experiment Video
Updated: May 6, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Epstein-Barr Virus Strongly Associates With Pediatric Multiple Sclerosis, But Not Myelin Oligodendrocyte
Giulia Fadda1, Carmen Yea2, Julia O'Mahony3
1Department of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Abstract:
Reported rates of Epstein-Barr virus (EBV) seropositivity in children meeting multiple sclerosis (MS) diagnostic criteria are considerably lower than those reported in adult-onset MS, putting in question a requisite role for EBV in MS development. As prior work preceded recognition of myelin oligodendrocyte glycoprotein-associated disease (MOGAD), we assessed viral serologies in 251 children with incident demyelination and prospectively ascertained diagnoses. When MOGAD was serologically accounted for, the prevalence of EBV infection among MS children exceeded 90%, whereas remote EBV infection was not associated with MOGAD risk. Together, these findings substantiate EBV's role across the MS spectrum, and support distinct pathobiological mechanisms in MS versus MOGAD. ANN NEUROL 2024;95:700-705.
Insights
Epstein-Barr virus (EBV) is strongly linked to pediatric multiple sclerosis (MS) when myelin oligodendrocyte glycoprotein-associated disease (MOGAD) is excluded. This study confirms EBV
Area of Science:
- Neurology
- Immunology
- Virology
Background:
- Pediatric multiple sclerosis (MS) shows lower Epstein-Barr virus (EBV) seropositivity than adult MS.
- Prior studies did not account for myelin oligodendrocyte glycoprotein-associated disease (MOGAD).
Purpose of the Study:
- To investigate the role of EBV in pediatric demyelinating diseases, including MS and MOGAD.
- To clarify EBV's association with MS in children after accounting for MOGAD.
Main Methods:
- Assessed viral serologies in 251 children with incident demyelination.
- Prospectively ascertained diagnoses of MS and MOGAD.
- Compared EBV seroprevalence between pediatric MS and MOGAD cohorts.
Main Results:
- EBV seroprevalence exceeded 90% in pediatric MS cases after excluding MOGAD.
- Remote EBV infection was not associated with an increased risk of MOGAD.
- Findings suggest distinct etiologies for MS and MOGAD.
Conclusions:
- Epstein-Barr virus plays a significant role across the spectrum of multiple sclerosis.
- The distinct pathobiological mechanisms of MS and MOGAD are supported by these findings.
- This research clarifies EBV's role in pediatric demyelinating diseases.
Related Concept Videos
Arboviral Encephalitis
Cytomegalovirus Disease
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction

